Clinical Trials Directory

Trials / Completed

CompletedNCT04024527

High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

Efficacy of High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori Rescue Treatment: A Randomized Clinical Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
306 (actual)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Dual therapy containing high dose of proton pump inhibitor (PPI) and amoxicillin had showed excellent eradication results with Helicobacter pylori first-line treatment. However, no study has examined the the efficacy of high dose of dual therapy or dual therapy plus metronidazole for H. pylori rescue treatment.This study is designed to evaluate the efficacy and safety of the addition of metronidazole to high dose of dual therapy for H. pylori rescue treatment.

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazoleProton pump inhibitor
DRUGAmoxicillinAntibiotic for H. pylori eradication
DRUGMetronidazoleAntibiotic for H. pylori eradication

Timeline

Start date
2019-07-25
Primary completion
2021-04-12
Completion
2021-05-24
First posted
2019-07-18
Last updated
2021-09-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04024527. Inclusion in this directory is not an endorsement.